Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965-2018.


Journal

Neuroepidemiology
ISSN: 1423-0208
Titre abrégé: Neuroepidemiology
Pays: Switzerland
ID NLM: 8218700

Informations de publication

Date de publication:
2019
Historique:
received: 05 06 2018
accepted: 14 09 2018
pubmed: 27 11 2018
medline: 20 12 2019
entrez: 27 11 2018
Statut: ppublish

Résumé

Previous studies, dating back to the 1960s disclosed a progressive increase in multiple sclerosis (MS) incidence and prevalence in the Province of Padua. To further analyze whether this trend is the effect of the improved diagnostic procedures or is primarily related to a real increase risk of MS, we analyzed MS incidence and prevalence of the 5-year period 2011-2015. Patients with a diagnosis of MS or clinically isolated syndrome highly suggestive of MS were included in the study. All available sources of clinical and administrative information were evaluated. Mean annual incidence in the 5-year period 2011-2015 and the prevalence on December 31, 2015 were calculated. The 2011-2015 mean incidence was 6.5/100,000/year, 7.9 for females, 4.1 for males. The overall prevalence was 182/100,000, 241 for females, 116 for males. Compared to the 2000-2009 period, mean age at onset, onset-diagnosis delay and F/M ratio did not significantly change. Since the 1960s, incidence and prevalence of MS linearly increased with no interposed plateau periods. MS incidence and prevalence further and significantly increased in the period 2011-2015. Our 1965-2015 data indicate a real increased risk of MS and stress a role of exogenous factors in MS susceptibility.

Sections du résumé

BACKGROUND
Previous studies, dating back to the 1960s disclosed a progressive increase in multiple sclerosis (MS) incidence and prevalence in the Province of Padua. To further analyze whether this trend is the effect of the improved diagnostic procedures or is primarily related to a real increase risk of MS, we analyzed MS incidence and prevalence of the 5-year period 2011-2015.
METHODS
Patients with a diagnosis of MS or clinically isolated syndrome highly suggestive of MS were included in the study. All available sources of clinical and administrative information were evaluated. Mean annual incidence in the 5-year period 2011-2015 and the prevalence on December 31, 2015 were calculated.
RESULTS
The 2011-2015 mean incidence was 6.5/100,000/year, 7.9 for females, 4.1 for males. The overall prevalence was 182/100,000, 241 for females, 116 for males. Compared to the 2000-2009 period, mean age at onset, onset-diagnosis delay and F/M ratio did not significantly change. Since the 1960s, incidence and prevalence of MS linearly increased with no interposed plateau periods.
CONCLUSIONS
MS incidence and prevalence further and significantly increased in the period 2011-2015. Our 1965-2015 data indicate a real increased risk of MS and stress a role of exogenous factors in MS susceptibility.

Identifiants

pubmed: 30476909
pii: 000493857
doi: 10.1159/000493857
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-46

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Francesca Grassivaro (F)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Marco Puthenparampil (M)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Marta Pengo (M)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Martina Saiani (M)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Martina Venturini (M)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Erica Stropparo (E)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Paola Perini (P)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Francesca Rinaldi (F)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy.

Nicoletta Freddi (N)

Unit of Neurology, Saint Antony Hospital, Padua and Piove di Sacco, Padua, Italy.

Morena Cadaldini (M)

Unit of Neurology, General Hospital of Schiavonia-Monselice, Padua, Italy.

Luisella Colledan (L)

Unit of Neurology, General Hospital of Camposampiero, Padua, Italy.

Maria Grazia Piccinno (MG)

Unit of Neurology, General Hospital of Cittadella, Padua, Italy.

Elisabetta Pedrazzoli (E)

The Italian Multiple Sclerosis Society (AISM), Padua, Italy.

Paolo Gallo (P)

The Multiple Sclerosis Center of the Veneto Region, Department of Neurosciences, University of Padua, Padua, Italy, paolo.gallo@unipd.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH